Doppler echocardiography underestimates the prevalence and magnitude of mid-cavity obstruction in patients with symptomatic hypertrophic cardiomyopathy-Reference-Cited by-同舟云学术

Doppler echocardiography underestimates the prevalence and magnitude of mid-cavity obstruction in patients with symptomatic hypertrophic cardiomyopathy

Published:2017-08-02 Issue:4 Volume:91 Page:783-789
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Malcolmson James W.¹^ORCID,Hamshere Stephen M.¹²,Joshi Abhishek¹²,O'Mahony Constantinos¹³,Dhinoja Mehul¹,Petersen Steffen E.¹²⁴,Sekhri Neha¹,Mohiddin Saidi A.¹²⁴

Affiliation:

1. Barts Heart Centre, Barts Health NHS Trust, Whitechapel, London E1 1BB; United Kingdom

2. William Harvey Research Institute, Queen Mary University of London; United Kingdom

3. UCL Centre for Heart Muscle Disease; Institute of Cardiovascular Science, University College London; Gower St London WC1E United Kingdom

4. NIHR Biomedical Research Unit at Barts; London United Kingdom

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference18 articles.

1. Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases;Elliott;Eur Heart J,2008

2. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography;Nagueh;J Am Soc Echocardiogr,2011

3. Clinical practice. Hypertrophic obstructive cardiomyopathy;Nishimura;N Engl J Med,2004

4. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur Heart J,2014

5. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy;Minami;J Am Coll Cardiol,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized Pacing;Circulation: Arrhythmia and Electrophysiology;2024-07

2. Obstruction in Hypertrophic Cardiomyopathy: Many Faces;Journal of the American Society of Echocardiography;2024-06

3. Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized Pacing;2023-12-20

4. Application of Cardiovascular Computed Tomography to the Assessment of Patients With Hypertrophic Cardiomyopathy;The American Journal of Cardiology;2023-10

5. Multimodality imaging of hypertrophic cardiomyopathy;Progress in Cardiovascular Diseases;2023-09